Meeting
Abstract Number: 99
SHM Converge 2023
Background: Since the start of the COVID-19 pandemic, racial and ethnic minorities have experienced disparities in infection rates, hospitalization, and death. Monoclonal antibodies (Mab) decrease hospitalization when given to ambulatory non-severe high-risk patients within 10 day of symptom onset. Disparities in care related to Mabs are not well understood. We describe experience from Mab infusion […]
Abstract Number: 797
SHM Converge 2023
Case Presentation: We present a 31-year-old female patient with a medical history significant for Stage II Breast cancer on Chemo and Immunotherapy (Pembrolizumab) who presents to the Emergency Department for the evaluation of nausea, vomiting, and generalized abdominal pain for 1 day. On arrival, the vital signs were within normal limits. On physical examination, generalized […]